文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

外周微循环改变与入住中间呼吸病房和重症监护室的COVID-19患者急性呼吸窘迫综合征严重程度相关

Peripheral microcirculatory alterations are associated with the severity of acute respiratory distress syndrome in COVID-19 patients admitted to intermediate respiratory and intensive care units.
PubMed 文献 · Crit Care · 2021-11-08
一句话结论重症COVID-19患者存在提示内皮功能障碍的全身微循环改变,且这些改变与ARDS严重程度相关,但能否用于预后判断尚需进一步评估。

这项前瞻性观察研究在西班牙、墨西哥和巴西开展,用近红外光谱(NIRS)结合3分钟血管闭塞试验(VOT)测量前臂局部组织氧饱和度(StO2)、局部血红蛋白浓度(THC)及动态参数DeO2、ReO2、HAUC,比较32名健康对照与73例因低氧血症入住中间呼吸病房(IRCU)和ICU的重症COVID-19患者,并以SpO2/FiO2(SF比值)评估ARDS严重程度。结果显示两组基线StO2和THC无差异,但COVID-19患者VOT动态参数显著受损,表现为代谢率(DeO2)降低和内皮反应性减弱;基线StO2和DeO2与SF比值负相关,ReO2与SF比值正相关;不同ARDS组间基线StO2和ReO2存在显著差异,而不同呼吸支持方式间无差异。作者认为这些改变提示内皮功能障碍并与ARDS严重程度相关,但需进一步评估其预后意义;该结果为正在进行的HEMOCOVID-19试验的中期结果。

要点

  • 重症COVID-19患者VOT动态参数显著受损:DeO2降低(代谢率下降)、内皮反应性减弱,而基线StO2和THC与健康对照无差异。
  • 基线StO2和DeO2与SF比值负相关,ReO2与SF比值正相关,提示微循环改变与ARDS严重程度相关。
  • 按SF比值划分的不同ARDS组间基线StO2和ReO2存在显著差异,但不同呼吸支持治疗间无差异。
  • 入组时53%患者接受有创机械通气、32%接受经鼻高流量氧疗;机械通气患者中100%使用镇静药物、29%使用血管升压药。
  • 作者认为这些微循环改变提示内皮功能障碍并与ARDS严重程度相关,但需进一步评估其预后意义;结果为HEMOCOVID-19试验中期结果。

适用人群与场景

  • 因低氧血症入住中间呼吸病房(IRCU)和ICU的重症COVID-19患者,研究在西班牙、墨西哥和巴西开展。
  • 对照为健康受试者。

诊断标准与关键阈值

  • 以SpO2与FiO2的比值(SF比值)评估COVID-19患者ARDS严重程度。
  • 血管闭塞试验(VOT)为3分钟诱导缺血,用于获取动态StO2参数:去氧速率(DeO2)、复氧速率(ReO2)和高充血反应(HAUC)。
  • 用近红外光谱(NIRS)无创测量前臂局部组织/血氧饱和度(StO2)和局部血红蛋白浓度(THC)。

研究设计与关键结果

  • 前瞻性观察研究,纳入健康对照32名和COVID-19患者73例。
  • 两组基线StO2和THC无差异;COVID-19患者VOT动态参数显著受损,表现为代谢率(DeO2)降低和内皮反应性减弱。
  • 入组时53%的COVID-19患者接受有创机械通气,32%接受经鼻高流量氧疗;机械通气患者中100%使用镇静药物、29%使用血管升压药。
  • 基线StO2和DeO2与SF比值负相关,ReO2与SF比值正相关。
  • 按SF比值划分的不同ARDS组间基线StO2和ReO2存在显著差异,不同呼吸支持治疗间无差异。
  • 该结果为正在进行的HEMOCOVID-19试验(ClinicalTrials.gov NCT04689477,2020年12月30日回顾性注册)的中期结果。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究。
  • 局限:原文报告需进一步评估以确定这些观察是否具有预后意义。

对床旁实践的改变

  • 作者认为重症COVID-19患者存在提示内皮功能障碍的全身微循环改变,且这些改变与ARDS严重程度相关。
  • 作者指出需进一步评估以确定这些观察是否具有预后意义。

指南或共识出处

  • HEMOCOVID-19试验(ClinicalTrials.gov NCT04689477,2020年12月30日回顾性注册)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: COVID-19 is primarily a respiratory disease; however, there is also evidence that it causes endothelial damage in the microvasculature of several organs. The aim of the present study is to characterize in vivo the microvascular reactivity in peripheral skeletal muscle of severe COVID-19 patients.

METHODS: This is a prospective observational study carried out in Spain, Mexico and Brazil. Healthy subjects and severe COVID-19 patients admitted to the intermediate respiratory (IRCU) and intensive care units (ICU) due to hypoxemia were studied. Local tissue/blood oxygen saturation (StO2) and local hemoglobin concentration (THC) were non-invasively measured on the forearm by near-infrared spectroscopy (NIRS). A vascular occlusion test (VOT), a three-minute induced ischemia, was performed in order to obtain dynamic StO2 parameters: deoxygenation rate (DeO2), reoxygenation rate (ReO2), and hyperemic response (HAUC). In COVID-19 patients, the severity of ARDS was evaluated by the ratio between peripheral arterial oxygen saturation (SpO2) and the fraction of inspired oxygen (FiO2) (SF ratio).

RESULTS: Healthy controls (32) and COVID-19 patients (73) were studied. Baseline StO2 and THC did not differ between the two groups. Dynamic VOT-derived parameters were significantly impaired in COVID-19 patients showing lower metabolic rate (DeO2) and diminished endothelial reactivity. At enrollment, most COVID-19 patients were receiving invasive mechanical ventilation (MV) (53%) or high-flow nasal cannula support (32%). Patients on MV were also receiving sedative agents (100%) and vasopressors (29%). Baseline StO2 and DeO2 negatively correlated with SF ratio, while ReO2 showed a positive correlation with SF ratio. There were significant differences in baseline StO2 and ReO2 among the different ARDS groups according to SF ratio, but not among different respiratory support therapies.

CONCLUSION: Patients with severe COVID-19 show systemic microcirculatory alterations suggestive of endothelial dysfunction, and these alterations are associated with the severity of ARDS. Further evaluation is needed to determine whether these observations have prognostic implications. These results represent interim findings of the ongoing HEMOCOVID-19 trial. Trial registration ClinicalTrials.gov NCT04689477 . Retrospectively registered 30 December 2020.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Mesquida J, Caballer A, Cortese L, et al. Peripheral microcirculatory alterations are associated with the severity of acute respiratory distress syndrome in COVID-19 patients admitted to intermediate respiratory and intensive care units. Crit Care. 2021. PMID: 34749792. doi:10.1186/s13054-021-03803-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。